Melatonin: A potential protective multifaceted force for sepsis-induced cardiomyopathy

Area of Science:

• Cardiology
• Pharmacology
• Immunology

Background:

• Sepsis is a life-threatening organ dysfunction from infection.
• Sepsis-induced cardiomyopathy (SIC) is a common cause of death, characterized by biventricular dysfunction and dilatation.
• Current sepsis management lacks effective pharmacological treatments for SIC.

Purpose of the Study:

• To review the potential of melatonin in managing sepsis-induced cardiomyopathy (SIC).
• To explore melatonin's multifaceted mechanisms against SIC pathogenesis.

Main Methods:

• Literature review of studies on melatonin and sepsis-induced organ dysfunction.
• Analysis of melatonin's pharmacological activities, including antioxidant, anti-inflammatory, and antimicrobial properties.
• Examination of melatonin's effects on pathways involved in SIC, such as oxidative stress, inflammation, and mitochondrial dysfunction.

Main Results:

• Melatonin exhibits significant antioxidant activity by scavenging reactive oxygen and nitrogen species.
• Melatonin's anti-inflammatory effects help control cytokine storms and immune dysregulation.
• Melatonin mitigates mitochondrial dysfunction and apoptosis, key mechanisms in SIC.

Conclusions:

• Melatonin demonstrates promising potential for treating sepsis-induced cardiomyopathy due to its diverse protective actions.
• Targeting multiple pathways with melatonin may be more effective than single-pathway interventions for SIC.
• Further research into melatonin as a therapeutic agent for SIC is warranted.